Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Immunologic Cytotoxicity. Found 13 abstracts

Shemesh A, Brusilovsky M, Kundu K, Ottolenghi A, Campbell KS, Porgador A. Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints. Cancer immunology, immunotherapy : CII. 2018 Dec;67(12):1871-83.
Higuchi T, Flies DB, Marjon NA, Mantia-Smaldone G, Ronner L, Gimotty PA, Adams S. CTLA-4 blockade synergizes therapeutically with PARP-inhibition in BRCA1-deficient ovarian cancer. Cancer Immunol Res. 2015 Jul 02;3(11):1257-68.   PMCID: 4984269
Anikeeva N, Steblyanko M, Fayngerts S, Kopylova N, Marshall DJ, Powers GD, Sato T, Campbell KS, Sykulev Y. Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity. European Journal of Immunology. 2014 Aug;44(8):2331-9.   PMCID: 4141007
Purdy AK, Alvarez Arias DA, Oshinsky J, James AM, Serebriiskii I, Campbell KS. The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells. J Immunol. 2014 Nov;193(9):4675-83.   PMCID: 4269369
Purdy AK, Campbell KS. SHP-2 expression negatively regulates NK cell function. J Immunol. 2009 Dec;183(11):7234-43.   PMCID: PMC2783243
MacFarlane AW, Yamazaki T, Fang M, Sigal LJ, Kurosaki T, Campbell KS. Enhanced NK-cell development and function in BCAP-deficient mice. Blood. 2008 Jul;112(1):131-40.
Alvarez-Arias DA, Campbell KS. Protein kinase C regulates expression and function of inhibitory killer cell Ig-like receptors in NK cells. J Immunol. 2007 Oct 15;179(8):5281-90.
Conejo-Garcia JR, Benencia F, Courreges MC, Khang E, Zhang L, Mohamed-Hadley A, Vinocur JM, Buckanovich RJ, Thompson CB, Levine B, Coukos G. Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer Biol Ther. 2003 Jul;2(4):446-51.
Lacorazza HD, Miyazaki Y, Di Cristofano A, Deblasio A, Hedvat C, Zhang J, Cordon-Cardo C, Mao S, Pandolfi PP, Nimer SD. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity. 2002 Oct;17(4):437-49.
Yusa S, Catina TL, Campbell KS. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J Immunol. 2002 May 15;168(10):5047-57.
Link BK, Weiner GJ. Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cells. Blood. 1993 Jun 15;81(12):3343-9.
Weiner LM, Holmes M, Richeson A, Godwin A, Adams GP, Hsieh-Ma ST, Ring DB, Alpaugh RK. Binding and cytotoxicity characteristics of the bispecific murine monoclonal antibody 2B1. Journal of Immunology. 1993 Jan;151(5):2877-86.
Leu RW, Norton TR, Herriott MJ, Ringer DP, Kearns RJ. Suppression of natural killer and lymphocyte functions associated with carcinogen-induced premalignant hyperplastic nodules in rat liver. Cancer Research. 1985 Jul;45(7):3282-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Immunologic Cytotoxicity

Immunologic Cytotoxicity immunology Natural Killer Cells genetics metabolism biosynthesis Cell Line physiology pathology deficiency Mice Signal Transduction Cultured Tumor Cells antagonists & inhibitors Lymphocyte Activation Interferon-gamma Inbred C57BL Mice US Gov't Support-PHS Monoclonal Antibodies KIR Receptors Non-US Gov't Support Immunologic Receptors Female Amino Acid Sequence Knockout Mice chemistry enzymology Molecular Sequence Data Human B-Lymphocytes Male KIR3DL1 Receptors Lymphocytes Interferon Type II Immunoglobulin G T-Lymphocyte Subsets drug effects Apoptosis Ovarian Neoplasms Antibodies Phosphorylation pharmacology Gene Expression Regulation methods therapeutic use Protein Binding Combined Modality Therapy Transformed Cell Line Membrane Glycoproteins Gene Knockdown Techniques Colonic Neoplasms Intercellular Adhesion Molecule-1 Microtubules Immune checkpoints 1-Phosphatidylinositol 3-Kinase Protein Interaction Domains and Motifs Inflammation Down-Regulation Ligands GPI-Linked Proteins Immunologic Cytotoxicity Tests Antineoplastic Agents Proto-Oncogene Proteins c-akt T-Lymphocytes Hyperplasia Isoforms Amino Acid Sequence Homology Neoplasm Transplantation NKp46 Phospholipase C Adhesion receptors Cytoplasm Phosphotyrosine Up-Regulation In Vitro Immunological Models Innate Immunity Serine Cytokines Signal Transducing Adaptor Proteins Tumor cells Cytoskeleton cancer immunology Lymphopoiesis Drug Dose-Response Relationship Alternative Splicing Neoplasm Antigens Adcc NK cells Protein Kinase C Immunotherapy Western Blotting K562 Cells monoclonal antibody Gene Expression Profiling Antigen Receptors-T-Cell Rats Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Tretinoin antibody specificity Endocytosis Integrin alphaV Congenic Mice NKp44 11 Peptide Fragments Inbred F344 Rats Amino Acid Motifs CD8-Positive T-Lymphocytes Non-Receptor Type Protein Tyrosine Phosphatase Threonine Experimental Liver Neoplasms CTLA-4 Antigen Cell Aging Site-Directed Mutagenesis Cell Culture src Homology Domains Self Tolerance Cytoplasmic Granules Vaccinia virus Endosomes Hybridomas Amino Acid Substitution Immune Tolerance gamma-Glutamyltransferase Protein-Tyrosine-Phosphatase Granzymes drug therapy Genetic Transduction Transcription Factors Tertiary Protein Structure administration & dosage NKp30 Glutamic Acid Cellular Microenvironment Interleukin-2 Ubiquitin-Protein Ligases Splice variants cytotoxicity Substrate Specificity Precancerous Conditions Tumor Cell Line IgG Receptors Messenger RNA Protein Subunits DNA-Binding Proteins therapy Liver Adaptor Protein Complex 2 Histocompatibility Antigens Class I
Last updated on Friday, January 03, 2020